Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials